Table 3 Prognostic influence of clinical and serologic parameters on hearing gain (∆6PTA) ≥10 dB absolute hearing gain

Gender

0.160

Age

0.176

Side

0.624

Tinnitus

0.133

Vertigo

0.574

Smoker

0.586

Comorbidity (Charlson Index ≥1)

0.435

Vascular risk factor

0.402

Low-frequency hearing loss

<0.0001

Start of inpatient treatment <4 days after onset

0.018

Interval between first and last audiogram

0.065

First SSNHL

0.001

Contralateral ear with normal hearing

0.159

Initial hearing loss ≥ 60 dB

<0.0001

aPTT, normal

0.905

Quick, lower than normal

0.040

Fibrinogen (g/l), high (hyperfibrinogenemia)

0.007

Red-cell count (Tptl/l) women

0.611

Red-cell count (Tptl/l) men

0.593

Hemoglobin (mmol/l) women

0.901

Hemoglobin (mmol/l) men

0.946

Hematocrit women

0.727

Hematocrit men

0.086

White-cell count (/μl)

0.433

Platelet count (Gpt/l)

0.749

MCH

0.456

MCHC

0.445

MCV

0.582

Glucose (mmol/l)

0.078

Sodium (mmol/l)

0.656

Potassium (mmol/l)

0.164

Calcium (mmol/l)

0.273

Urea (mmol/l)

0.694

Creatinine (lmol/l) women

0.116

Creatinine (lmol/l) men

0.497

C-reactive protein (mg/l)

0.380

Cholesterol (mmol/l)

0.088

LDL (mmol/l)

0.131

HDL (mmol/l)

0.922

LDL/HDL

0.367

Triglycerides (mmol/l)

0.970